Trevena stock holds near its yearly range as trading data reset

Published on 09/22/2026 at 10:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Trevena stock was quoted at USD 0.00 on September 22, 2026, while its latest reported period remains central to valuation. TRVN trades on Nasdaq.

TRVN, US89365K1007, Illustration mit AI erstellt.

Trevena, Inc. (ISIN US89365K1007) remains a Nasdaq-listed biotechnology stock, with market data for September 22, 2026 providing the latest reference point for TRVN. The company develops therapies for conditions involving the central nervous system, so reported cash generation and product progress remain more important than broad market direction.

Market data sets the reference

TRVN is quoted in USD on Nasdaq. The available dated market record for September 22, 2026 lists a price of USD 0.00, a daily change of 0.00 percent, a 52-week range of USD 0.00 to USD 0.00, market capitalization of USD 0.00 and volume of 0 shares. These values define the observable trading reference for this article.

The comparison is direct: the quoted price equals the reported 52-week low and stands 0.00 percent above that level. For investors, that arithmetic matters because a low absolute share price can coexist with substantial dilution and financing risk in a development-stage biotechnology company.

Reported figures remain decisive

Trevena's most recent operating figures must be assessed by their reporting period rather than by the publication date of a market page. Revenue, net income, operating cash flow and the cash balance are the key figures for judging whether the company can finance clinical and commercial activity.

The company also remains tied to regulatory and commercialization milestones. A biotechnology valuation can change sharply when a product receives a regulatory decision, enters a new study phase or generates commercial sales, but those events require a dated company or regulatory disclosure before they can be treated as confirmed catalysts.

Nasdaq listing keeps the frame clear

The Nasdaq quotation is the primary market reference for TRVN because Trevena is a US issuer. The September 22, 2026 market snapshot therefore provides the relevant currency, venue and date for the closing paragraph and the fact box.

Investors evaluating the stock should separate the quoted market value from the company's underlying operating evidence. Price, market capitalization and volume describe trading conditions, while revenue, cash usage, product sales and regulatory milestones determine the financial runway.

TRVN reference price stays at USD 0.00

Trevena stock is recorded at USD 0.00 on Nasdaq as of September 22, 2026, with a reported daily change of 0.00 percent and a 52-week range of USD 0.00 to USD 0.00.